Accéder au contenu
Merck
Toutes les photos(2)

Principaux documents

810120C

Avanti

18:0 PEG2000 PE CF

Avanti Research - A Croda Brand 810120C

Synonyme(s) :

1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[poly(ethylene glycol)2000-N′-carboxyfluorescein] (ammonium salt)

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme


About This Item

Numéro CAS:
Numéro MDL:
Code UNSPSC :
12352211
Nomenclature NACRES :
NA.25

Essai

>99% (TLC)

Forme

liquid

Conditionnement

pkg of 1 × 1 mL (810120C-1mg)
pkg of 1 × 1 mL (810120C-500ug)

Fabricant/nom de marque

Avanti Research - A Croda Brand 810120C

Concentration

0.5 mg/mL (810120C-500ug)
1 mg/mL (810120C-1mg)

Conditions d'expédition

dry ice

Température de stockage

−20°C

Description générale

1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[poly(ethylene glycol)2000-N′-carboxyfluorescein] (18:0 PEG2000 PE CF) lipid comprises hydrophilic polyethylene glycol (PEG) polymer in its head groups.

Application

18:0 PEG2000 PE CF may be used:
  • in in vitro release assays from nanoemulsion (NE)
  • for the labeling PEGylated LPD (liposome-polycation-DNA) for size exclusion chromatography studies
  • as a fluorescent probe to monitor shape transformation in giant vesicles

Actions biochimiques/physiologiques

1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[poly(ethylene glycol)2000-N′-carboxyfluorescein] (18:0 PEG2000 PE CF) conjugate is useful in designing biointerfaces. Lipid-anchored poly(ethylene glycol) (PEG) polymers aid in liposomal drug delivery. PEG-PE liposomes aid in the controlled release of drugs and are promising drug carriers. 18:0 PEG2000 PE CF, also called the DSPE−PEG2000, is a stable polymeric micelle, which favors hydrophobic drug circulation by preventing uptake by mononuclear phagocyte system. DSPE−PEG2000 is a potential drug carrier for cancer therapy.

Conditionnement

5 mL Clear Glass Sealed Ampule (810120C-1mg)
5 mL Clear Glass Sealed Ampule (810120C-500ug)

Informations légales

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Pictogrammes

Skull and crossbonesHealth hazard

Mention d'avertissement

Danger

Classification des risques

Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3

Organes cibles

Central nervous system, Liver,Kidney

Classe de danger pour l'eau (WGK)

WGK 3


Faites votre choix parmi les versions les plus récentes :

Certificats d'analyse (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

Si vous avez besoin d'assistance, veuillez contacter Service Clients

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

PEG-Lipid Post Insertion into Drug Delivery Liposomes Quantified at the Single Liposome Level
Eliasen R, et al.
Advanced Materials Interfaces, 6(9), 1801807-1801807 (2019)
Repeated injections of PEG-PE liposomes generate anti-PEG antibodies
Sroda K, et al.
Cellular & Molecular Biology Letters, 10, 37-47 (2005)
Nanoparticles evading the reticuloendothelial system: role of the supported bilayer
Li SD and Huang L
Biochimica et Biophysica Acta - Biomembranes, 1788(10), 2259-2266 (2009)
Molecular-matched materials for anticancer drug delivery and imaging
Wang D, et al.
Nanomedicine : nanotechnology, biology, and medicine, 10(19), 3003-3013 (2015)
Shape Transformations of Lipid Vesicles by Insertion of Bulky-Head Lipids
Tsuda S, et al.
PLoS ONE, 10(7), e0132963-e0132963 (2015)

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique